The current LRMR market cap is 449.79M. The company's latest EPS is USD -0.5791 and P/E is -1.71.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.51M | -10.44M | -7.64M | -9.62M | -10.34M |
Net Income | -8.32M | -9.43M | -6.53M | -8.37M | -9.06M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -45.65M | -42.8M | -50.47M | -36.53M | -41.76M |
Net Income | -45.41M | -42.48M | -50.64M | -35.36M | -36.95M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 133.02M | 126.41M | 118.91M | 111.72M | 103.95M |
Total Liabilities | 14.35M | 15.5M | 12.67M | 11.79M | 11.24M |
Total Equity | 118.66M | 110.9M | 106.24M | 99.93M | 92.71M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 80.73M | 104.69M | 78.67M | 126.41M | 95.94M |
Total Liabilities | 27.11M | 14.99M | 14.25M | 15.5M | 14.22M |
Total Equity | 53.62M | 89.69M | 64.41M | 110.9M | 81.72M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -20.9M | -27.57M | -7.55M | -14.92M | -24.12M |
Investing | -38.73M | -90.96M | 92.25M | 82.41M | 35.98M |
Financing | 75.57M | 75.26M | N/A | N/A | 30k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -40.78M | -42.2M | -42.11M | -27.57M | -33.46M |
Investing | 25.26M | 17.09M | 24.17M | -90.96M | 33.35M |
Financing | -5.26M | 93.59M | 19.89M | 75.26M | 30k |
Market Cap | 449.79M |
Price to Earnings Ratio | -1.71 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.36 |
Price to Book Ratio | 0.77 |
Dividend Yield | - |
Shares Outstanding | 63.8M |
Average Volume (1 week) | 295.59k |
Average Volume (1 Month) | 425.99k |
52 Week Change | 51.29% |
52 Week High | 13.68 |
52 Week Low | 2.18 |
Spread (Intraday) | 0.8 (10.85%) |
Company Name | Larimar Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://larimartx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.